HOG Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
Harley-Davidson is not a good buy right now for a beginner long-term investor with $50,000-$100,000 to deploy. The stock lacks a clear bullish setup, faces weak fundamental momentum, and has multiple near-term negatives ahead of earnings. With no AI Stock Picker or SwingMax buy signal, soft analyst sentiment, falling revenue, and a product recall hitting right before earnings, I would not buy it now.
HOG is trading pre-market at 23.9, just above pivot support at 23.561 and below resistance at 24.393. The MACD histogram is negative and still below zero, showing downside momentum even if it is contracting slightly. RSI_6 at 66.6 suggests the stock is near mildly overbought territory rather than deeply oversold. Moving averages are converging, which points to indecision rather than a confirmed uptrend. Overall, the current price action is neutral-to-weak, and the setup does not support an aggressive long-term entry.
["Insiders are buying, and buying activity increased 624.82% over the last month.", "Analysts still include a few constructive views, with D.A. Davidson at Buy and BMO at Outperform.", "The stock is near its pivot support area, which could attract short-term buyers if earnings surprise positively."]
["No AI Stock Picker signal today.", "No SwingMax signal recently.", "A recall of 88,039 motorcycles was announced on 2026-05-01, creating a fresh operational and brand negative.", "Analyst sentiment has weakened sharply, including Wells Fargo initiating Underweight with a $15 target and UBS cutting its target to $19.", "Recent financials show revenue down 27.84% YoY and gross margin collapsing to 3.42% in Q4 2025.", "Congress trading data shows 1 sale and 0 buys in the last 90 days.", "Trend model suggests weak near-term performance, with negative expected moves over the next day, week, and month.", "Earnings are due on 2026-05-05 pre-market, increasing event risk in the immediate term."]
In Q4 2025, Harley-Davidson showed weak operating performance. Revenue fell to 496.2M, down 27.84% YoY, which is a major decline in growth. Gross margin dropped sharply to 3.42%, indicating significant pressure on profitability. Net income remained negative at -279.3M, and EPS was -2.44, though both improved versus the prior year because losses were smaller than before. The latest quarter does not show a healthy growth trend; it reflects a turnaround story still under strain.
Analyst sentiment has turned more cautious recently. Wells Fargo initiated coverage with an Underweight rating and a $15 target, citing prolonged underperformance and weak demand. UBS cut its target to $19 from $27 and kept Neutral. Morgan Stanley lowered its target to $12 and stayed Underweight. A few firms remain positive, such as D.A. Davidson with Buy and BMO with Outperform, but even those notes acknowledged weak guidance and a difficult operating backdrop. Wall Street’s overall view is mixed to bearish, with more recent revisions leaning negative.
